nodes	percent_of_prediction	percent_of_DWPC	metapath
Amoxapine—Desloratadine—Loratadine—atopic dermatitis	0.554	1	CrCrCtD
Amoxapine—ORM1—Tacrolimus—atopic dermatitis	0.0942	0.345	CbGbCtD
Amoxapine—HRH1—Dimenhydrinate—atopic dermatitis	0.0733	0.269	CbGbCtD
Amoxapine—HRH1—Loratadine—atopic dermatitis	0.0358	0.131	CbGbCtD
Amoxapine—HRH1—Diphenhydramine—atopic dermatitis	0.0358	0.131	CbGbCtD
Amoxapine—CYP2D6—Loratadine—atopic dermatitis	0.0143	0.0524	CbGbCtD
Amoxapine—CYP2D6—Diphenhydramine—atopic dermatitis	0.0143	0.0524	CbGbCtD
Amoxapine—CYP2D6—Dexamethasone—atopic dermatitis	0.00495	0.0181	CbGbCtD
Amoxapine—Weight increased—Triamcinolone—atopic dermatitis	0.000178	0.00157	CcSEcCtD
Amoxapine—Weight increased—Methylprednisolone—atopic dermatitis	0.000178	0.00157	CcSEcCtD
Amoxapine—Hypotension—Tacrolimus—atopic dermatitis	0.000177	0.00156	CcSEcCtD
Amoxapine—Pruritus—Fluocinolone Acetonide—atopic dermatitis	0.000177	0.00156	CcSEcCtD
Amoxapine—Vomiting—Loratadine—atopic dermatitis	0.000177	0.00156	CcSEcCtD
Amoxapine—Rash—Loratadine—atopic dermatitis	0.000175	0.00154	CcSEcCtD
Amoxapine—Dermatitis—Loratadine—atopic dermatitis	0.000175	0.00154	CcSEcCtD
Amoxapine—Headache—Loratadine—atopic dermatitis	0.000174	0.00153	CcSEcCtD
Amoxapine—Acute coronary syndrome—Triamcinolone—atopic dermatitis	0.000172	0.00152	CcSEcCtD
Amoxapine—Acute coronary syndrome—Methylprednisolone—atopic dermatitis	0.000172	0.00152	CcSEcCtD
Amoxapine—Insomnia—Tacrolimus—atopic dermatitis	0.000172	0.00151	CcSEcCtD
Amoxapine—Myocardial infarction—Triamcinolone—atopic dermatitis	0.000171	0.00151	CcSEcCtD
Amoxapine—Asthenia—Mometasone—atopic dermatitis	0.000171	0.00151	CcSEcCtD
Amoxapine—Myocardial infarction—Methylprednisolone—atopic dermatitis	0.000171	0.00151	CcSEcCtD
Amoxapine—Diarrhoea—Fluocinolone Acetonide—atopic dermatitis	0.000171	0.00151	CcSEcCtD
Amoxapine—Paraesthesia—Tacrolimus—atopic dermatitis	0.00017	0.0015	CcSEcCtD
Amoxapine—Somnolence—Tacrolimus—atopic dermatitis	0.000169	0.00149	CcSEcCtD
Amoxapine—Pruritus—Mometasone—atopic dermatitis	0.000169	0.00149	CcSEcCtD
Amoxapine—Dyspepsia—Tacrolimus—atopic dermatitis	0.000167	0.00147	CcSEcCtD
Amoxapine—Hallucination—Hydrocortisone—atopic dermatitis	0.000166	0.00146	CcSEcCtD
Amoxapine—Dizziness—Fluocinolone Acetonide—atopic dermatitis	0.000165	0.00146	CcSEcCtD
Amoxapine—Nausea—Loratadine—atopic dermatitis	0.000165	0.00145	CcSEcCtD
Amoxapine—Decreased appetite—Tacrolimus—atopic dermatitis	0.000165	0.00145	CcSEcCtD
Amoxapine—Fatigue—Tacrolimus—atopic dermatitis	0.000164	0.00144	CcSEcCtD
Amoxapine—Diarrhoea—Mometasone—atopic dermatitis	0.000163	0.00144	CcSEcCtD
Amoxapine—Constipation—Tacrolimus—atopic dermatitis	0.000162	0.00143	CcSEcCtD
Amoxapine—Weight increased—Dexamethasone—atopic dermatitis	0.000162	0.00143	CcSEcCtD
Amoxapine—Weight increased—Betamethasone—atopic dermatitis	0.000162	0.00143	CcSEcCtD
Amoxapine—Vomiting—Fluocinolone Acetonide—atopic dermatitis	0.000159	0.0014	CcSEcCtD
Amoxapine—Rash—Fluocinolone Acetonide—atopic dermatitis	0.000157	0.00139	CcSEcCtD
Amoxapine—Dermatitis—Fluocinolone Acetonide—atopic dermatitis	0.000157	0.00139	CcSEcCtD
Amoxapine—Headache—Fluocinolone Acetonide—atopic dermatitis	0.000156	0.00138	CcSEcCtD
Amoxapine—Feeling abnormal—Tacrolimus—atopic dermatitis	0.000156	0.00138	CcSEcCtD
Amoxapine—Acute coronary syndrome—Betamethasone—atopic dermatitis	0.000156	0.00138	CcSEcCtD
Amoxapine—Acute coronary syndrome—Dexamethasone—atopic dermatitis	0.000156	0.00138	CcSEcCtD
Amoxapine—Hallucination—Methylprednisolone—atopic dermatitis	0.000156	0.00137	CcSEcCtD
Amoxapine—Myocardial infarction—Dexamethasone—atopic dermatitis	0.000155	0.00137	CcSEcCtD
Amoxapine—Myocardial infarction—Betamethasone—atopic dermatitis	0.000155	0.00137	CcSEcCtD
Amoxapine—Gastrointestinal pain—Tacrolimus—atopic dermatitis	0.000155	0.00137	CcSEcCtD
Amoxapine—Pancreatitis—Prednisone—atopic dermatitis	0.000152	0.00134	CcSEcCtD
Amoxapine—Vomiting—Mometasone—atopic dermatitis	0.000152	0.00134	CcSEcCtD
Amoxapine—Urticaria—Tacrolimus—atopic dermatitis	0.000151	0.00133	CcSEcCtD
Amoxapine—Rash—Mometasone—atopic dermatitis	0.00015	0.00132	CcSEcCtD
Amoxapine—Dermatitis—Mometasone—atopic dermatitis	0.00015	0.00132	CcSEcCtD
Amoxapine—Body temperature increased—Tacrolimus—atopic dermatitis	0.00015	0.00132	CcSEcCtD
Amoxapine—Abdominal pain—Tacrolimus—atopic dermatitis	0.00015	0.00132	CcSEcCtD
Amoxapine—Headache—Mometasone—atopic dermatitis	0.000149	0.00132	CcSEcCtD
Amoxapine—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.000148	0.00131	CcSEcCtD
Amoxapine—Erectile dysfunction—Prednisone—atopic dermatitis	0.000143	0.00126	CcSEcCtD
Amoxapine—Hallucination—Dexamethasone—atopic dermatitis	0.000142	0.00125	CcSEcCtD
Amoxapine—Hallucination—Betamethasone—atopic dermatitis	0.000142	0.00125	CcSEcCtD
Amoxapine—Nausea—Mometasone—atopic dermatitis	0.000142	0.00125	CcSEcCtD
Amoxapine—Weight increased—Prednisone—atopic dermatitis	0.000141	0.00124	CcSEcCtD
Amoxapine—Vision blurred—Prednisolone—atopic dermatitis	0.00014	0.00123	CcSEcCtD
Amoxapine—Asthenia—Tacrolimus—atopic dermatitis	0.000136	0.0012	CcSEcCtD
Amoxapine—Acute coronary syndrome—Prednisone—atopic dermatitis	0.000136	0.0012	CcSEcCtD
Amoxapine—Myocardial infarction—Prednisone—atopic dermatitis	0.000135	0.00119	CcSEcCtD
Amoxapine—Pruritus—Tacrolimus—atopic dermatitis	0.000134	0.00118	CcSEcCtD
Amoxapine—Dysgeusia—Triamcinolone—atopic dermatitis	0.000134	0.00118	CcSEcCtD
Amoxapine—Syncope—Prednisolone—atopic dermatitis	0.000133	0.00117	CcSEcCtD
Amoxapine—Loss of consciousness—Prednisolone—atopic dermatitis	0.000131	0.00115	CcSEcCtD
Amoxapine—Syncope—Hydrocortisone—atopic dermatitis	0.00013	0.00115	CcSEcCtD
Amoxapine—Diarrhoea—Tacrolimus—atopic dermatitis	0.00013	0.00114	CcSEcCtD
Amoxapine—Convulsion—Prednisolone—atopic dermatitis	0.000129	0.00113	CcSEcCtD
Amoxapine—Hypertension—Prednisolone—atopic dermatitis	0.000128	0.00113	CcSEcCtD
Amoxapine—Loss of consciousness—Hydrocortisone—atopic dermatitis	0.000128	0.00112	CcSEcCtD
Amoxapine—Alopecia—Betamethasone—atopic dermatitis	0.000126	0.00111	CcSEcCtD
Amoxapine—Alopecia—Dexamethasone—atopic dermatitis	0.000126	0.00111	CcSEcCtD
Amoxapine—Convulsion—Hydrocortisone—atopic dermatitis	0.000126	0.00111	CcSEcCtD
Amoxapine—Dizziness—Tacrolimus—atopic dermatitis	0.000126	0.00111	CcSEcCtD
Amoxapine—Hypertension—Hydrocortisone—atopic dermatitis	0.000125	0.0011	CcSEcCtD
Amoxapine—Hallucination—Prednisone—atopic dermatitis	0.000123	0.00109	CcSEcCtD
Amoxapine—Syncope—Triamcinolone—atopic dermatitis	0.000123	0.00108	CcSEcCtD
Amoxapine—Syncope—Methylprednisolone—atopic dermatitis	0.000122	0.00108	CcSEcCtD
Amoxapine—Oedema—Prednisolone—atopic dermatitis	0.000121	0.00107	CcSEcCtD
Amoxapine—Vomiting—Tacrolimus—atopic dermatitis	0.000121	0.00106	CcSEcCtD
Amoxapine—Loss of consciousness—Triamcinolone—atopic dermatitis	0.00012	0.00106	CcSEcCtD
Amoxapine—Loss of consciousness—Methylprednisolone—atopic dermatitis	0.00012	0.00106	CcSEcCtD
Amoxapine—Rash—Tacrolimus—atopic dermatitis	0.00012	0.00105	CcSEcCtD
Amoxapine—Dermatitis—Tacrolimus—atopic dermatitis	0.00012	0.00105	CcSEcCtD
Amoxapine—Shock—Prednisolone—atopic dermatitis	0.000119	0.00105	CcSEcCtD
Amoxapine—Headache—Tacrolimus—atopic dermatitis	0.000119	0.00105	CcSEcCtD
Amoxapine—Oedema—Hydrocortisone—atopic dermatitis	0.000118	0.00104	CcSEcCtD
Amoxapine—Convulsion—Triamcinolone—atopic dermatitis	0.000118	0.00104	CcSEcCtD
Amoxapine—Tachycardia—Prednisolone—atopic dermatitis	0.000118	0.00104	CcSEcCtD
Amoxapine—Convulsion—Methylprednisolone—atopic dermatitis	0.000118	0.00104	CcSEcCtD
Amoxapine—Hypertension—Triamcinolone—atopic dermatitis	0.000118	0.00104	CcSEcCtD
Amoxapine—Hypertension—Methylprednisolone—atopic dermatitis	0.000118	0.00104	CcSEcCtD
Amoxapine—Shock—Hydrocortisone—atopic dermatitis	0.000116	0.00103	CcSEcCtD
Amoxapine—Tachycardia—Hydrocortisone—atopic dermatitis	0.000116	0.00102	CcSEcCtD
Amoxapine—Dry mouth—Triamcinolone—atopic dermatitis	0.000114	0.001	CcSEcCtD
Amoxapine—Anorexia—Hydrocortisone—atopic dermatitis	0.000113	0.000994	CcSEcCtD
Amoxapine—Nausea—Tacrolimus—atopic dermatitis	0.000113	0.000993	CcSEcCtD
Amoxapine—Confusional state—Methylprednisolone—atopic dermatitis	0.000112	0.000988	CcSEcCtD
Amoxapine—Oedema—Triamcinolone—atopic dermatitis	0.000111	0.000982	CcSEcCtD
Amoxapine—Syncope—Dexamethasone—atopic dermatitis	0.000111	0.000979	CcSEcCtD
Amoxapine—Syncope—Betamethasone—atopic dermatitis	0.000111	0.000979	CcSEcCtD
Amoxapine—Hypotension—Hydrocortisone—atopic dermatitis	0.000111	0.000975	CcSEcCtD
Amoxapine—Shock—Triamcinolone—atopic dermatitis	0.00011	0.000967	CcSEcCtD
Amoxapine—Insomnia—Prednisolone—atopic dermatitis	0.00011	0.000966	CcSEcCtD
Amoxapine—Alopecia—Prednisone—atopic dermatitis	0.00011	0.000966	CcSEcCtD
Amoxapine—Shock—Methylprednisolone—atopic dermatitis	0.000109	0.000964	CcSEcCtD
Amoxapine—Loss of consciousness—Dexamethasone—atopic dermatitis	0.000109	0.00096	CcSEcCtD
Amoxapine—Loss of consciousness—Betamethasone—atopic dermatitis	0.000109	0.00096	CcSEcCtD
Amoxapine—Paraesthesia—Prednisolone—atopic dermatitis	0.000109	0.000959	CcSEcCtD
Amoxapine—Tachycardia—Triamcinolone—atopic dermatitis	0.000109	0.000959	CcSEcCtD
Amoxapine—Tachycardia—Methylprednisolone—atopic dermatitis	0.000109	0.000957	CcSEcCtD
Amoxapine—Convulsion—Dexamethasone—atopic dermatitis	0.000107	0.000946	CcSEcCtD
Amoxapine—Convulsion—Betamethasone—atopic dermatitis	0.000107	0.000946	CcSEcCtD
Amoxapine—Insomnia—Hydrocortisone—atopic dermatitis	0.000107	0.000944	CcSEcCtD
Amoxapine—Hypertension—Dexamethasone—atopic dermatitis	0.000107	0.000943	CcSEcCtD
Amoxapine—Hypertension—Betamethasone—atopic dermatitis	0.000107	0.000943	CcSEcCtD
Amoxapine—Paraesthesia—Hydrocortisone—atopic dermatitis	0.000106	0.000937	CcSEcCtD
Amoxapine—Dyspepsia—Hydrocortisone—atopic dermatitis	0.000104	0.000918	CcSEcCtD
Amoxapine—Hypotension—Methylprednisolone—atopic dermatitis	0.000104	0.000916	CcSEcCtD
Amoxapine—Decreased appetite—Hydrocortisone—atopic dermatitis	0.000103	0.000907	CcSEcCtD
Amoxapine—Fatigue—Hydrocortisone—atopic dermatitis	0.000102	0.000899	CcSEcCtD
Amoxapine—Vision blurred—Prednisone—atopic dermatitis	0.000102	0.000896	CcSEcCtD
Amoxapine—Oedema—Betamethasone—atopic dermatitis	0.000101	0.000891	CcSEcCtD
Amoxapine—Oedema—Dexamethasone—atopic dermatitis	0.000101	0.000891	CcSEcCtD
Amoxapine—Insomnia—Triamcinolone—atopic dermatitis	0.000101	0.000889	CcSEcCtD
Amoxapine—Insomnia—Methylprednisolone—atopic dermatitis	0.000101	0.000887	CcSEcCtD
Amoxapine—Paraesthesia—Triamcinolone—atopic dermatitis	0.0001	0.000882	CcSEcCtD
Amoxapine—Feeling abnormal—Prednisolone—atopic dermatitis	9.99e-05	0.00088	CcSEcCtD
Amoxapine—Paraesthesia—Methylprednisolone—atopic dermatitis	9.99e-05	0.00088	CcSEcCtD
Amoxapine—Shock—Betamethasone—atopic dermatitis	9.95e-05	0.000877	CcSEcCtD
Amoxapine—Shock—Dexamethasone—atopic dermatitis	9.95e-05	0.000877	CcSEcCtD
Amoxapine—Agitation—Prednisone—atopic dermatitis	9.92e-05	0.000874	CcSEcCtD
Amoxapine—Thrombocytopenia—Dexamethasone—atopic dermatitis	9.9e-05	0.000873	CcSEcCtD
Amoxapine—Thrombocytopenia—Betamethasone—atopic dermatitis	9.9e-05	0.000873	CcSEcCtD
Amoxapine—Tachycardia—Betamethasone—atopic dermatitis	9.87e-05	0.00087	CcSEcCtD
Amoxapine—Tachycardia—Dexamethasone—atopic dermatitis	9.87e-05	0.00087	CcSEcCtD
Amoxapine—Dyspepsia—Triamcinolone—atopic dermatitis	9.81e-05	0.000865	CcSEcCtD
Amoxapine—Dyspepsia—Methylprednisolone—atopic dermatitis	9.79e-05	0.000863	CcSEcCtD
Amoxapine—Feeling abnormal—Hydrocortisone—atopic dermatitis	9.76e-05	0.00086	CcSEcCtD
Amoxapine—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	9.68e-05	0.000853	CcSEcCtD
Amoxapine—Syncope—Prednisone—atopic dermatitis	9.68e-05	0.000853	CcSEcCtD
Amoxapine—Anorexia—Dexamethasone—atopic dermatitis	9.64e-05	0.00085	CcSEcCtD
Amoxapine—Anorexia—Betamethasone—atopic dermatitis	9.64e-05	0.00085	CcSEcCtD
Amoxapine—Urticaria—Prednisolone—atopic dermatitis	9.63e-05	0.000849	CcSEcCtD
Amoxapine—Fatigue—Triamcinolone—atopic dermatitis	9.61e-05	0.000847	CcSEcCtD
Amoxapine—Fatigue—Methylprednisolone—atopic dermatitis	9.59e-05	0.000845	CcSEcCtD
Amoxapine—Loss of consciousness—Prednisone—atopic dermatitis	9.49e-05	0.000836	CcSEcCtD
Amoxapine—Hypotension—Dexamethasone—atopic dermatitis	9.45e-05	0.000833	CcSEcCtD
Amoxapine—Hypotension—Betamethasone—atopic dermatitis	9.45e-05	0.000833	CcSEcCtD
Amoxapine—Urticaria—Hydrocortisone—atopic dermatitis	9.41e-05	0.000829	CcSEcCtD
Amoxapine—Body temperature increased—Hydrocortisone—atopic dermatitis	9.36e-05	0.000825	CcSEcCtD
Amoxapine—Abdominal pain—Hydrocortisone—atopic dermatitis	9.36e-05	0.000825	CcSEcCtD
Amoxapine—Convulsion—Prednisone—atopic dermatitis	9.35e-05	0.000824	CcSEcCtD
Amoxapine—Hypertension—Prednisone—atopic dermatitis	9.32e-05	0.000821	CcSEcCtD
Amoxapine—Feeling abnormal—Triamcinolone—atopic dermatitis	9.19e-05	0.00081	CcSEcCtD
Amoxapine—Feeling abnormal—Methylprednisolone—atopic dermatitis	9.17e-05	0.000808	CcSEcCtD
Amoxapine—Insomnia—Betamethasone—atopic dermatitis	9.15e-05	0.000806	CcSEcCtD
Amoxapine—Insomnia—Dexamethasone—atopic dermatitis	9.15e-05	0.000806	CcSEcCtD
Amoxapine—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	9.1e-05	0.000802	CcSEcCtD
Amoxapine—Paraesthesia—Dexamethasone—atopic dermatitis	9.08e-05	0.0008	CcSEcCtD
Amoxapine—Paraesthesia—Betamethasone—atopic dermatitis	9.08e-05	0.0008	CcSEcCtD
Amoxapine—Dyspepsia—Betamethasone—atopic dermatitis	8.9e-05	0.000785	CcSEcCtD
Amoxapine—Dyspepsia—Dexamethasone—atopic dermatitis	8.9e-05	0.000785	CcSEcCtD
Amoxapine—Urticaria—Triamcinolone—atopic dermatitis	8.86e-05	0.00078	CcSEcCtD
Amoxapine—Urticaria—Methylprednisolone—atopic dermatitis	8.84e-05	0.000779	CcSEcCtD
Amoxapine—Body temperature increased—Triamcinolone—atopic dermatitis	8.81e-05	0.000777	CcSEcCtD
Amoxapine—Oedema—Prednisone—atopic dermatitis	8.81e-05	0.000776	CcSEcCtD
Amoxapine—Abdominal pain—Methylprednisolone—atopic dermatitis	8.79e-05	0.000775	CcSEcCtD
Amoxapine—Decreased appetite—Dexamethasone—atopic dermatitis	8.79e-05	0.000775	CcSEcCtD
Amoxapine—Decreased appetite—Betamethasone—atopic dermatitis	8.79e-05	0.000775	CcSEcCtD
Amoxapine—Fatigue—Betamethasone—atopic dermatitis	8.72e-05	0.000768	CcSEcCtD
Amoxapine—Fatigue—Dexamethasone—atopic dermatitis	8.72e-05	0.000768	CcSEcCtD
Amoxapine—Shock—Prednisone—atopic dermatitis	8.67e-05	0.000764	CcSEcCtD
Amoxapine—Tachycardia—Prednisone—atopic dermatitis	8.6e-05	0.000758	CcSEcCtD
Amoxapine—Asthenia—Hydrocortisone—atopic dermatitis	8.5e-05	0.000749	CcSEcCtD
Amoxapine—Anorexia—Prednisone—atopic dermatitis	8.4e-05	0.00074	CcSEcCtD
Amoxapine—Pruritus—Hydrocortisone—atopic dermatitis	8.38e-05	0.000738	CcSEcCtD
Amoxapine—Feeling abnormal—Dexamethasone—atopic dermatitis	8.34e-05	0.000735	CcSEcCtD
Amoxapine—Feeling abnormal—Betamethasone—atopic dermatitis	8.34e-05	0.000735	CcSEcCtD
Amoxapine—Gastrointestinal pain—Dexamethasone—atopic dermatitis	8.27e-05	0.000729	CcSEcCtD
Amoxapine—Gastrointestinal pain—Betamethasone—atopic dermatitis	8.27e-05	0.000729	CcSEcCtD
Amoxapine—Diarrhoea—Hydrocortisone—atopic dermatitis	8.1e-05	0.000714	CcSEcCtD
Amoxapine—Urticaria—Betamethasone—atopic dermatitis	8.04e-05	0.000708	CcSEcCtD
Amoxapine—Urticaria—Dexamethasone—atopic dermatitis	8.04e-05	0.000708	CcSEcCtD
Amoxapine—Dizziness—Prednisolone—atopic dermatitis	8.02e-05	0.000706	CcSEcCtD
Amoxapine—Asthenia—Triamcinolone—atopic dermatitis	8e-05	0.000705	CcSEcCtD
Amoxapine—Body temperature increased—Dexamethasone—atopic dermatitis	8e-05	0.000705	CcSEcCtD
Amoxapine—Abdominal pain—Betamethasone—atopic dermatitis	8e-05	0.000705	CcSEcCtD
Amoxapine—Abdominal pain—Dexamethasone—atopic dermatitis	8e-05	0.000705	CcSEcCtD
Amoxapine—Body temperature increased—Betamethasone—atopic dermatitis	8e-05	0.000705	CcSEcCtD
Amoxapine—Asthenia—Methylprednisolone—atopic dermatitis	7.98e-05	0.000703	CcSEcCtD
Amoxapine—Insomnia—Prednisone—atopic dermatitis	7.97e-05	0.000702	CcSEcCtD
Amoxapine—Paraesthesia—Prednisone—atopic dermatitis	7.91e-05	0.000697	CcSEcCtD
Amoxapine—Pruritus—Triamcinolone—atopic dermatitis	7.89e-05	0.000695	CcSEcCtD
Amoxapine—Pruritus—Methylprednisolone—atopic dermatitis	7.87e-05	0.000693	CcSEcCtD
Amoxapine—Dizziness—Hydrocortisone—atopic dermatitis	7.83e-05	0.00069	CcSEcCtD
Amoxapine—Dyspepsia—Prednisone—atopic dermatitis	7.75e-05	0.000683	CcSEcCtD
Amoxapine—Decreased appetite—Prednisone—atopic dermatitis	7.66e-05	0.000675	CcSEcCtD
Amoxapine—Rash—Prednisolone—atopic dermatitis	7.64e-05	0.000674	CcSEcCtD
Amoxapine—Dermatitis—Prednisolone—atopic dermatitis	7.64e-05	0.000673	CcSEcCtD
Amoxapine—Diarrhoea—Methylprednisolone—atopic dermatitis	7.61e-05	0.000671	CcSEcCtD
Amoxapine—Fatigue—Prednisone—atopic dermatitis	7.6e-05	0.000669	CcSEcCtD
Amoxapine—Headache—Prednisolone—atopic dermatitis	7.6e-05	0.000669	CcSEcCtD
Amoxapine—Constipation—Prednisone—atopic dermatitis	7.53e-05	0.000664	CcSEcCtD
Amoxapine—Vomiting—Hydrocortisone—atopic dermatitis	7.53e-05	0.000663	CcSEcCtD
Amoxapine—Rash—Hydrocortisone—atopic dermatitis	7.47e-05	0.000658	CcSEcCtD
Amoxapine—Dermatitis—Hydrocortisone—atopic dermatitis	7.46e-05	0.000657	CcSEcCtD
Amoxapine—Headache—Hydrocortisone—atopic dermatitis	7.42e-05	0.000654	CcSEcCtD
Amoxapine—Dizziness—Triamcinolone—atopic dermatitis	7.37e-05	0.00065	CcSEcCtD
Amoxapine—Dizziness—Methylprednisolone—atopic dermatitis	7.36e-05	0.000648	CcSEcCtD
Amoxapine—Feeling abnormal—Prednisone—atopic dermatitis	7.26e-05	0.00064	CcSEcCtD
Amoxapine—Asthenia—Betamethasone—atopic dermatitis	7.26e-05	0.00064	CcSEcCtD
Amoxapine—Asthenia—Dexamethasone—atopic dermatitis	7.26e-05	0.00064	CcSEcCtD
Amoxapine—Gastrointestinal pain—Prednisone—atopic dermatitis	7.2e-05	0.000635	CcSEcCtD
Amoxapine—Nausea—Prednisolone—atopic dermatitis	7.2e-05	0.000635	CcSEcCtD
Amoxapine—Pruritus—Betamethasone—atopic dermatitis	7.16e-05	0.000631	CcSEcCtD
Amoxapine—Pruritus—Dexamethasone—atopic dermatitis	7.16e-05	0.000631	CcSEcCtD
Amoxapine—Vomiting—Triamcinolone—atopic dermatitis	7.09e-05	0.000625	CcSEcCtD
Amoxapine—Vomiting—Methylprednisolone—atopic dermatitis	7.07e-05	0.000623	CcSEcCtD
Amoxapine—Nausea—Hydrocortisone—atopic dermatitis	7.03e-05	0.00062	CcSEcCtD
Amoxapine—Rash—Triamcinolone—atopic dermatitis	7.03e-05	0.000619	CcSEcCtD
Amoxapine—Dermatitis—Triamcinolone—atopic dermatitis	7.02e-05	0.000619	CcSEcCtD
Amoxapine—Rash—Methylprednisolone—atopic dermatitis	7.01e-05	0.000618	CcSEcCtD
Amoxapine—Dermatitis—Methylprednisolone—atopic dermatitis	7.01e-05	0.000617	CcSEcCtD
Amoxapine—Urticaria—Prednisone—atopic dermatitis	7e-05	0.000617	CcSEcCtD
Amoxapine—Headache—Triamcinolone—atopic dermatitis	6.98e-05	0.000615	CcSEcCtD
Amoxapine—Headache—Methylprednisolone—atopic dermatitis	6.97e-05	0.000614	CcSEcCtD
Amoxapine—Body temperature increased—Prednisone—atopic dermatitis	6.96e-05	0.000614	CcSEcCtD
Amoxapine—Abdominal pain—Prednisone—atopic dermatitis	6.96e-05	0.000614	CcSEcCtD
Amoxapine—Diarrhoea—Betamethasone—atopic dermatitis	6.92e-05	0.00061	CcSEcCtD
Amoxapine—Diarrhoea—Dexamethasone—atopic dermatitis	6.92e-05	0.00061	CcSEcCtD
Amoxapine—Dizziness—Dexamethasone—atopic dermatitis	6.69e-05	0.000589	CcSEcCtD
Amoxapine—Dizziness—Betamethasone—atopic dermatitis	6.69e-05	0.000589	CcSEcCtD
Amoxapine—Nausea—Triamcinolone—atopic dermatitis	6.62e-05	0.000584	CcSEcCtD
Amoxapine—Nausea—Methylprednisolone—atopic dermatitis	6.61e-05	0.000582	CcSEcCtD
Amoxapine—Vomiting—Dexamethasone—atopic dermatitis	6.43e-05	0.000567	CcSEcCtD
Amoxapine—Vomiting—Betamethasone—atopic dermatitis	6.43e-05	0.000567	CcSEcCtD
Amoxapine—Rash—Dexamethasone—atopic dermatitis	6.38e-05	0.000562	CcSEcCtD
Amoxapine—Rash—Betamethasone—atopic dermatitis	6.38e-05	0.000562	CcSEcCtD
Amoxapine—Dermatitis—Dexamethasone—atopic dermatitis	6.37e-05	0.000562	CcSEcCtD
Amoxapine—Dermatitis—Betamethasone—atopic dermatitis	6.37e-05	0.000562	CcSEcCtD
Amoxapine—Headache—Betamethasone—atopic dermatitis	6.34e-05	0.000558	CcSEcCtD
Amoxapine—Headache—Dexamethasone—atopic dermatitis	6.34e-05	0.000558	CcSEcCtD
Amoxapine—Asthenia—Prednisone—atopic dermatitis	6.32e-05	0.000557	CcSEcCtD
Amoxapine—Pruritus—Prednisone—atopic dermatitis	6.23e-05	0.000549	CcSEcCtD
Amoxapine—Diarrhoea—Prednisone—atopic dermatitis	6.03e-05	0.000531	CcSEcCtD
Amoxapine—Nausea—Betamethasone—atopic dermatitis	6.01e-05	0.000529	CcSEcCtD
Amoxapine—Nausea—Dexamethasone—atopic dermatitis	6.01e-05	0.000529	CcSEcCtD
Amoxapine—Dizziness—Prednisone—atopic dermatitis	5.83e-05	0.000513	CcSEcCtD
Amoxapine—Vomiting—Prednisone—atopic dermatitis	5.6e-05	0.000494	CcSEcCtD
Amoxapine—Rash—Prednisone—atopic dermatitis	5.55e-05	0.000489	CcSEcCtD
Amoxapine—Dermatitis—Prednisone—atopic dermatitis	5.55e-05	0.000489	CcSEcCtD
Amoxapine—Headache—Prednisone—atopic dermatitis	5.52e-05	0.000486	CcSEcCtD
Amoxapine—Nausea—Prednisone—atopic dermatitis	5.23e-05	0.000461	CcSEcCtD
Amoxapine—ADRA2A—GPCR ligand binding—CXCL8—atopic dermatitis	1.19e-05	0.000199	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—CCR3—atopic dermatitis	1.17e-05	0.000196	CbGpPWpGaD
Amoxapine—HTR6—GPCR downstream signaling—CXCL8—atopic dermatitis	1.16e-05	0.000193	CbGpPWpGaD
Amoxapine—HTR7—GPCR downstream signaling—CXCL8—atopic dermatitis	1.16e-05	0.000193	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—IL5—atopic dermatitis	1.15e-05	0.000192	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—IL5—atopic dermatitis	1.14e-05	0.000191	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—CCL5—atopic dermatitis	1.14e-05	0.000191	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—CXCL10—atopic dermatitis	1.14e-05	0.000191	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—CCL5—atopic dermatitis	1.14e-05	0.00019	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—CCR5—atopic dermatitis	1.13e-05	0.000189	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—CXCL10—atopic dermatitis	1.13e-05	0.000188	CbGpPWpGaD
Amoxapine—HTR1B—GPCR downstream signaling—CXCL8—atopic dermatitis	1.13e-05	0.000188	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—CCL5—atopic dermatitis	1.12e-05	0.000188	CbGpPWpGaD
Amoxapine—ADRA2A—GPCR downstream signaling—CCR5—atopic dermatitis	1.11e-05	0.000186	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—CCR5—atopic dermatitis	1.11e-05	0.000186	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—CCR5—atopic dermatitis	1.11e-05	0.000185	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—CCL5—atopic dermatitis	1.11e-05	0.000185	CbGpPWpGaD
Amoxapine—DRD4—GPCR downstream signaling—CXCL8—atopic dermatitis	1.11e-05	0.000185	CbGpPWpGaD
Amoxapine—HTR6—GPCR downstream signaling—IL2—atopic dermatitis	1.11e-05	0.000185	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—CCR5—atopic dermatitis	1.11e-05	0.000185	CbGpPWpGaD
Amoxapine—HTR7—GPCR downstream signaling—IL2—atopic dermatitis	1.11e-05	0.000185	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CCR3—atopic dermatitis	1.09e-05	0.000182	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—CCL5—atopic dermatitis	1.09e-05	0.000182	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—CCR5—atopic dermatitis	1.09e-05	0.000182	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—TAC1—atopic dermatitis	1.09e-05	0.000182	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—NPS—atopic dermatitis	1.09e-05	0.000182	CbGpPWpGaD
Amoxapine—HTR1B—GPCR downstream signaling—IL2—atopic dermatitis	1.08e-05	0.00018	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—TAC1—atopic dermatitis	1.07e-05	0.000179	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—NPS—atopic dermatitis	1.07e-05	0.000179	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—TAC1—atopic dermatitis	1.07e-05	0.000178	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—NPS—atopic dermatitis	1.07e-05	0.000178	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—CXCR3—atopic dermatitis	1.07e-05	0.000178	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—NPS—atopic dermatitis	1.06e-05	0.000178	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—TAC1—atopic dermatitis	1.06e-05	0.000178	CbGpPWpGaD
Amoxapine—DRD4—GPCR downstream signaling—IL2—atopic dermatitis	1.06e-05	0.000177	CbGpPWpGaD
Amoxapine—HTR2B—GPCR downstream signaling—CXCL8—atopic dermatitis	1.06e-05	0.000177	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—NGF—atopic dermatitis	1.06e-05	0.000176	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—NGF—atopic dermatitis	1.06e-05	0.000176	CbGpPWpGaD
Amoxapine—HTR6—Signaling by GPCR—CXCL8—atopic dermatitis	1.05e-05	0.000176	CbGpPWpGaD
Amoxapine—HTR7—Signaling by GPCR—CXCL8—atopic dermatitis	1.05e-05	0.000176	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—CXCR3—atopic dermatitis	1.05e-05	0.000175	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—TAC1—atopic dermatitis	1.05e-05	0.000175	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—NPS—atopic dermatitis	1.05e-05	0.000175	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—CXCR3—atopic dermatitis	1.05e-05	0.000175	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—CXCL8—atopic dermatitis	1.05e-05	0.000175	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—CXCR3—atopic dermatitis	1.04e-05	0.000174	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—CCL5—atopic dermatitis	1.04e-05	0.000174	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—CCR5—atopic dermatitis	1.03e-05	0.000172	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—CXCR3—atopic dermatitis	1.03e-05	0.000171	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—NGF—atopic dermatitis	1.03e-05	0.000171	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—CCR5—atopic dermatitis	1.03e-05	0.000171	CbGpPWpGaD
Amoxapine—HTR1B—Signaling by GPCR—CXCL8—atopic dermatitis	1.02e-05	0.000171	CbGpPWpGaD
Amoxapine—ADRA2A—Hemostasis—IL2—atopic dermatitis	1.02e-05	0.00017	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—CCR5—atopic dermatitis	1.01e-05	0.000169	CbGpPWpGaD
Amoxapine—HTR2B—GPCR downstream signaling—IL2—atopic dermatitis	1.01e-05	0.000169	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—NGF—atopic dermatitis	1.01e-05	0.000169	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—IL5—atopic dermatitis	1.01e-05	0.000169	CbGpPWpGaD
Amoxapine—DRD4—Signaling by GPCR—CXCL8—atopic dermatitis	1.01e-05	0.000168	CbGpPWpGaD
Amoxapine—HTR6—Signaling by GPCR—IL2—atopic dermatitis	1.01e-05	0.000168	CbGpPWpGaD
Amoxapine—HTR7—Signaling by GPCR—IL2—atopic dermatitis	1e-05	0.000168	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—CCR5—atopic dermatitis	9.99e-06	0.000167	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—IL2—atopic dermatitis	9.99e-06	0.000167	CbGpPWpGaD
Amoxapine—DRD1—GPCR downstream signaling—CXCL8—atopic dermatitis	9.97e-06	0.000167	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—IL5—atopic dermatitis	9.94e-06	0.000166	CbGpPWpGaD
Amoxapine—HRH4—Signaling by GPCR—IL6—atopic dermatitis	9.94e-06	0.000166	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—IL5—atopic dermatitis	9.92e-06	0.000166	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—IL5—atopic dermatitis	9.89e-06	0.000165	CbGpPWpGaD
Amoxapine—DRD3—GPCR downstream signaling—CXCL8—atopic dermatitis	9.84e-06	0.000164	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—CCR5—atopic dermatitis	9.83e-06	0.000164	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—CCL5—atopic dermatitis	9.82e-06	0.000164	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—CXCL10—atopic dermatitis	9.81e-06	0.000164	CbGpPWpGaD
Amoxapine—HTR1B—Signaling by GPCR—IL2—atopic dermatitis	9.77e-06	0.000163	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—CXCL10—atopic dermatitis	9.76e-06	0.000163	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—IL5—atopic dermatitis	9.73e-06	0.000163	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—TAC1—atopic dermatitis	9.73e-06	0.000162	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—NPS—atopic dermatitis	9.73e-06	0.000162	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—CCL5—atopic dermatitis	9.69e-06	0.000162	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—NGF—atopic dermatitis	9.65e-06	0.000161	CbGpPWpGaD
Amoxapine—DRD4—Signaling by GPCR—IL2—atopic dermatitis	9.61e-06	0.000161	CbGpPWpGaD
Amoxapine—HTR2B—Signaling by GPCR—CXCL8—atopic dermatitis	9.6e-06	0.00016	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CXCR3—atopic dermatitis	9.54e-06	0.000159	CbGpPWpGaD
Amoxapine—DRD1—GPCR downstream signaling—IL2—atopic dermatitis	9.53e-06	0.000159	CbGpPWpGaD
Amoxapine—DRD3—GPCR downstream signaling—IL2—atopic dermatitis	9.4e-06	0.000157	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—CCR5—atopic dermatitis	9.38e-06	0.000157	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—MAPK8—atopic dermatitis	9.19e-06	0.000154	CbGpPWpGaD
Amoxapine—HTR2B—Signaling by GPCR—IL2—atopic dermatitis	9.18e-06	0.000153	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—NGF—atopic dermatitis	9.1e-06	0.000152	CbGpPWpGaD
Amoxapine—DRD1—Signaling by GPCR—CXCL8—atopic dermatitis	9.06e-06	0.000151	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—IL5—atopic dermatitis	9.05e-06	0.000151	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—NGF—atopic dermatitis	8.98e-06	0.00015	CbGpPWpGaD
Amoxapine—DRD3—Signaling by GPCR—CXCL8—atopic dermatitis	8.94e-06	0.000149	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—CCR5—atopic dermatitis	8.85e-06	0.000148	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—CCR5—atopic dermatitis	8.73e-06	0.000146	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—NFKBIA—atopic dermatitis	8.72e-06	0.000146	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—NFKBIA—atopic dermatitis	8.71e-06	0.000145	CbGpPWpGaD
Amoxapine—DRD1—Signaling by GPCR—IL2—atopic dermatitis	8.66e-06	0.000145	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—CXCL10—atopic dermatitis	8.62e-06	0.000144	CbGpPWpGaD
Amoxapine—HTR1A—GPCR downstream signaling—CXCL8—atopic dermatitis	8.58e-06	0.000143	CbGpPWpGaD
Amoxapine—DRD3—Signaling by GPCR—IL2—atopic dermatitis	8.54e-06	0.000143	CbGpPWpGaD
Amoxapine—HTR2C—GPCR downstream signaling—CXCL8—atopic dermatitis	8.53e-06	0.000142	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—CXCL10—atopic dermatitis	8.48e-06	0.000142	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—NFKBIA—atopic dermatitis	8.47e-06	0.000141	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—CXCL10—atopic dermatitis	8.46e-06	0.000141	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—CCL5—atopic dermatitis	8.45e-06	0.000141	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—CXCL10—atopic dermatitis	8.43e-06	0.000141	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—CCL5—atopic dermatitis	8.4e-06	0.00014	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—NFKBIA—atopic dermatitis	8.33e-06	0.000139	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—CXCL10—atopic dermatitis	8.3e-06	0.000139	CbGpPWpGaD
Amoxapine—HTR1A—GPCR downstream signaling—IL2—atopic dermatitis	8.2e-06	0.000137	CbGpPWpGaD
Amoxapine—HTR2C—GPCR downstream signaling—IL2—atopic dermatitis	8.15e-06	0.000136	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—NFKBIA—atopic dermatitis	7.96e-06	0.000133	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—NGF—atopic dermatitis	7.82e-06	0.000131	CbGpPWpGaD
Amoxapine—HTR1A—Signaling by GPCR—CXCL8—atopic dermatitis	7.79e-06	0.00013	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—NGF—atopic dermatitis	7.78e-06	0.00013	CbGpPWpGaD
Amoxapine—HTR2C—Signaling by GPCR—CXCL8—atopic dermatitis	7.75e-06	0.000129	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CXCL10—atopic dermatitis	7.71e-06	0.000129	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—CCR5—atopic dermatitis	7.61e-06	0.000127	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—CCR5—atopic dermatitis	7.57e-06	0.000126	CbGpPWpGaD
Amoxapine—DRD2—GPCR downstream signaling—CXCL8—atopic dermatitis	7.53e-06	0.000126	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—NFKBIA—atopic dermatitis	7.5e-06	0.000125	CbGpPWpGaD
Amoxapine—HTR1A—Signaling by GPCR—IL2—atopic dermatitis	7.44e-06	0.000124	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—CCL5—atopic dermatitis	7.42e-06	0.000124	CbGpPWpGaD
Amoxapine—HTR2A—GPCR downstream signaling—CXCL8—atopic dermatitis	7.41e-06	0.000124	CbGpPWpGaD
Amoxapine—HTR2C—Signaling by GPCR—IL2—atopic dermatitis	7.4e-06	0.000124	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—NFKBIA—atopic dermatitis	7.4e-06	0.000124	CbGpPWpGaD
Amoxapine—HRH1—GPCR downstream signaling—CXCL8—atopic dermatitis	7.39e-06	0.000123	CbGpPWpGaD
Amoxapine—CHRM1—GPCR downstream signaling—CXCL8—atopic dermatitis	7.37e-06	0.000123	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—CCL5—atopic dermatitis	7.3e-06	0.000122	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—CCL5—atopic dermatitis	7.28e-06	0.000122	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—CCL5—atopic dermatitis	7.26e-06	0.000121	CbGpPWpGaD
Amoxapine—ADRA1A—GPCR downstream signaling—CXCL8—atopic dermatitis	7.25e-06	0.000121	CbGpPWpGaD
Amoxapine—DRD2—GPCR downstream signaling—IL2—atopic dermatitis	7.2e-06	0.00012	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—CCL5—atopic dermatitis	7.15e-06	0.000119	CbGpPWpGaD
Amoxapine—HTR2A—GPCR downstream signaling—IL2—atopic dermatitis	7.08e-06	0.000118	CbGpPWpGaD
Amoxapine—HRH1—GPCR downstream signaling—IL2—atopic dermatitis	7.07e-06	0.000118	CbGpPWpGaD
Amoxapine—CHRM1—GPCR downstream signaling—IL2—atopic dermatitis	7.04e-06	0.000118	CbGpPWpGaD
Amoxapine—ADRA1A—GPCR downstream signaling—IL2—atopic dermatitis	6.93e-06	0.000116	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—NGF—atopic dermatitis	6.87e-06	0.000115	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—PPARA—atopic dermatitis	6.86e-06	0.000115	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—CXCL8—atopic dermatitis	6.84e-06	0.000114	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—NGF—atopic dermatitis	6.76e-06	0.000113	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—NGF—atopic dermatitis	6.74e-06	0.000113	CbGpPWpGaD
Amoxapine—ADRA2A—GPCR downstream signaling—CXCL8—atopic dermatitis	6.74e-06	0.000113	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—CXCL8—atopic dermatitis	6.73e-06	0.000112	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—NGF—atopic dermatitis	6.72e-06	0.000112	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—CXCL8—atopic dermatitis	6.71e-06	0.000112	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—CXCL8—atopic dermatitis	6.69e-06	0.000112	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—CCR5—atopic dermatitis	6.68e-06	0.000112	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CCL5—atopic dermatitis	6.64e-06	0.000111	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—NGF—atopic dermatitis	6.62e-06	0.000111	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—CXCL8—atopic dermatitis	6.59e-06	0.00011	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—CCR5—atopic dermatitis	6.57e-06	0.00011	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—CCR5—atopic dermatitis	6.56e-06	0.00011	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—CCR5—atopic dermatitis	6.54e-06	0.000109	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—IL2—atopic dermatitis	6.53e-06	0.000109	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—NFKBIA—atopic dermatitis	6.45e-06	0.000108	CbGpPWpGaD
Amoxapine—ADRA2A—GPCR downstream signaling—IL2—atopic dermatitis	6.44e-06	0.000108	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—CCR5—atopic dermatitis	6.44e-06	0.000108	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—IL2—atopic dermatitis	6.43e-06	0.000107	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—NFKBIA—atopic dermatitis	6.42e-06	0.000107	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—IL2—atopic dermatitis	6.42e-06	0.000107	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—IL2—atopic dermatitis	6.4e-06	0.000107	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—IL2—atopic dermatitis	6.3e-06	0.000105	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—CXCL8—atopic dermatitis	6.22e-06	0.000104	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—CXCL8—atopic dermatitis	6.21e-06	0.000104	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—NGF—atopic dermatitis	6.15e-06	0.000103	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—CXCL8—atopic dermatitis	6.12e-06	0.000102	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—CXCL8—atopic dermatitis	6.04e-06	0.000101	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CCR5—atopic dermatitis	5.98e-06	9.99e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—CXCL8—atopic dermatitis	5.94e-06	9.92e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—IL2—atopic dermatitis	5.94e-06	9.92e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—IL2—atopic dermatitis	5.93e-06	9.91e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling by GPCR—IL6—atopic dermatitis	5.91e-06	9.87e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling by GPCR—IL6—atopic dermatitis	5.9e-06	9.86e-05	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—IL6—atopic dermatitis	5.87e-06	9.8e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—IL2—atopic dermatitis	5.85e-06	9.77e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—IL2—atopic dermatitis	5.77e-06	9.64e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling by GPCR—IL6—atopic dermatitis	5.74e-06	9.59e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—IL2—atopic dermatitis	5.68e-06	9.49e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—CXCL8—atopic dermatitis	5.67e-06	9.47e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—NFKBIA—atopic dermatitis	5.66e-06	9.46e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling by GPCR—IL6—atopic dermatitis	5.65e-06	9.44e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—NFKBIA—atopic dermatitis	5.57e-06	9.31e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—NFKBIA—atopic dermatitis	5.56e-06	9.29e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—NFKBIA—atopic dermatitis	5.54e-06	9.26e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—MAPK8—atopic dermatitis	5.47e-06	9.13e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—MAPK8—atopic dermatitis	5.46e-06	9.12e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—NFKBIA—atopic dermatitis	5.46e-06	9.11e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—IL2—atopic dermatitis	5.42e-06	9.05e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling by GPCR—IL6—atopic dermatitis	5.39e-06	9.01e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—CXCL8—atopic dermatitis	5.35e-06	8.93e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—MAPK8—atopic dermatitis	5.31e-06	8.87e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—CXCL8—atopic dermatitis	5.28e-06	8.82e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—MAPK8—atopic dermatitis	5.23e-06	8.73e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—IL2—atopic dermatitis	5.11e-06	8.54e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling by GPCR—IL6—atopic dermatitis	5.09e-06	8.5e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—NFKBIA—atopic dermatitis	5.07e-06	8.47e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—IL2—atopic dermatitis	5.05e-06	8.43e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling by GPCR—IL6—atopic dermatitis	5.02e-06	8.38e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—MAPK8—atopic dermatitis	4.99e-06	8.33e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—MAPK8—atopic dermatitis	4.71e-06	7.86e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—MAPK8—atopic dermatitis	4.64e-06	7.75e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—CXCL8—atopic dermatitis	4.6e-06	7.68e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—CXCL8—atopic dermatitis	4.58e-06	7.64e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—PPARA—atopic dermatitis	4.47e-06	7.46e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—IL2—atopic dermatitis	4.4e-06	7.34e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling by GPCR—IL6—atopic dermatitis	4.37e-06	7.31e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—IL2—atopic dermatitis	4.37e-06	7.3e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling by GPCR—IL6—atopic dermatitis	4.35e-06	7.27e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—MAPK8—atopic dermatitis	4.05e-06	6.76e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—CXCL8—atopic dermatitis	4.04e-06	6.75e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—MAPK8—atopic dermatitis	4.03e-06	6.72e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—CXCL8—atopic dermatitis	3.97e-06	6.64e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—CXCL8—atopic dermatitis	3.97e-06	6.62e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—CXCL8—atopic dermatitis	3.95e-06	6.6e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—CXCL8—atopic dermatitis	3.89e-06	6.5e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—IL2—atopic dermatitis	3.86e-06	6.45e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—IL6—atopic dermatitis	3.84e-06	6.41e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—IL2—atopic dermatitis	3.8e-06	6.34e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—IL2—atopic dermatitis	3.79e-06	6.33e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—IL6—atopic dermatitis	3.78e-06	6.31e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—IL2—atopic dermatitis	3.78e-06	6.31e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—IL6—atopic dermatitis	3.77e-06	6.3e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—IL6—atopic dermatitis	3.76e-06	6.28e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—IL2—atopic dermatitis	3.72e-06	6.21e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—IL6—atopic dermatitis	3.7e-06	6.18e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CXCL8—atopic dermatitis	3.62e-06	6.04e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—MAPK8—atopic dermatitis	3.55e-06	5.93e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—MAPK8—atopic dermatitis	3.5e-06	5.84e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—IL6—atopic dermatitis	3.49e-06	5.83e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—MAPK8—atopic dermatitis	3.49e-06	5.83e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—IL6—atopic dermatitis	3.49e-06	5.82e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—MAPK8—atopic dermatitis	3.48e-06	5.81e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—IL2—atopic dermatitis	3.46e-06	5.77e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—IL6—atopic dermatitis	3.44e-06	5.74e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—MAPK8—atopic dermatitis	3.42e-06	5.72e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—IL6—atopic dermatitis	3.39e-06	5.67e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—IL6—atopic dermatitis	3.34e-06	5.58e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—IL6—atopic dermatitis	3.19e-06	5.32e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—MAPK8—atopic dermatitis	3.18e-06	5.31e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—IL6—atopic dermatitis	3.01e-06	5.02e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—IL6—atopic dermatitis	2.97e-06	4.95e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—IL6—atopic dermatitis	2.58e-06	4.32e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—IL6—atopic dermatitis	2.57e-06	4.29e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—IL6—atopic dermatitis	2.27e-06	3.79e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—IL6—atopic dermatitis	2.23e-06	3.73e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—IL6—atopic dermatitis	2.23e-06	3.72e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—IL6—atopic dermatitis	2.22e-06	3.71e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—IL6—atopic dermatitis	2.19e-06	3.65e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—IL6—atopic dermatitis	2.03e-06	3.39e-05	CbGpPWpGaD
